As of 2024-12-13, the Relative Valuation of XBiotech Inc (XBIT) is (9.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.93 USD, the upside of XBiotech Inc based on Relative Valuation is -230.8%.
The range of the Relative Valuation is (8.12) - (10.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.1x - 17.3x | 17.1x |
| Forward P/E multiples | 5.2x - 13.4x | 5.4x |
| Fair Price | (8.12) - (10.83) | (9.06) |
| Upside | -217.2% - -256.2% | -230.8% |
| Date | P/E |
| 2024-12-11 | -8.66 |
| 2024-12-10 | -8.23 |
| 2024-12-09 | -8.14 |
| 2024-12-06 | -7.94 |
| 2024-12-05 | -7.83 |
| 2024-12-04 | -8.07 |
| 2024-12-03 | -8.35 |
| 2024-12-02 | -8.88 |
| 2024-11-29 | -9.45 |
| 2024-11-27 | -9.12 |
| 2024-11-26 | -8.45 |
| 2024-11-25 | -8.52 |
| 2024-11-22 | -8.48 |
| 2024-11-21 | -8.22 |
| 2024-11-20 | -8.06 |
| 2024-11-19 | -8.28 |
| 2024-11-18 | -8.28 |
| 2024-11-15 | -8.27 |
| 2024-11-14 | -8.65 |
| 2024-11-13 | -8.81 |
| 2024-11-12 | -8.80 |
| 2024-11-11 | -9.06 |
| 2024-11-08 | -9.37 |
| 2024-11-07 | -9.14 |
| 2024-11-06 | -10.24 |
| 2024-11-05 | -9.26 |
| 2024-11-04 | -9.06 |
| 2024-11-01 | -9.12 |
| 2024-10-31 | -9.01 |
| 2024-10-30 | -9.17 |
| 2024-10-29 | -8.88 |
| 2024-10-28 | -9.57 |
| 2024-10-25 | -8.90 |
| 2024-10-24 | -8.99 |
| 2024-10-23 | -8.86 |
| 2024-10-22 | -9.32 |
| 2024-10-21 | -9.40 |
| 2024-10-18 | -9.37 |
| 2024-10-17 | -9.36 |
| 2024-10-16 | -9.57 |
| 2024-10-15 | -9.25 |
| 2024-10-14 | -9.56 |
| 2024-10-11 | -9.25 |
| 2024-10-10 | -8.65 |
| 2024-10-09 | -8.79 |
| 2024-10-08 | -8.54 |
| 2024-10-07 | -8.92 |
| 2024-10-04 | -9.28 |
| 2024-10-03 | -8.75 |
| 2024-10-02 | -9.31 |